TCC
TCC Pharma is a privately-held, Phoenix-based secondary pharmaceutical and medical-supply distributor serving 500-3,500 healthcare facilities across 45 states with hard-to-find, backordered, and allocated medications under DSCSA-compliant EPCIS 1.2 GS1 standards.
- Company typePrivate
- Founded2001
- HeadquartersPhoenix, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What TCC does
TCC (The Compounding Center, DBA TCC Pharma) is a privately-held, secondary pharmaceutical and medical-supply distributor founded in 2001 and headquartered in Phoenix, Arizona. The company sources and distributes brand-name and generic pharmaceuticals (excluding controlled substances and compounded medications) along with medical and surgical supplies, specializing in hard-to-find, backordered, and allocated products that primary distributors cannot fulfill. Its catalog spans 100,000+ NDCs and medical-supply SKUs, supported by relationships with verified manufacturers and authorized distributors, and is sold to hospitals, integrated delivery networks (IDNs), ambulatory surgery centers (ASCs), specialty clinics, veterinary facilities, federal and state government healthcare agencies (DoD, NIH, VA, IHS, HHS, Federal Prisons), medical wholesalers, and research organizations across 45 states.
TCC's technical platform centers on DSCSA-compliant serialized transaction data exchange via EPCIS 1.2 GS1 standards, with Gateway Checker certification and EDI connectivity over AS2 and SFTP protocols to trading partners including GS1 US, LSPediA, TraceLink, SAP, McKesson, Systech, Movilitas, Optel, and Trust.med. The company is layering a customer portal (pricing, quoting, order history, tracking, EPCIS file downloads) and a drug-shortage early-alert subscription service on top of its core distribution operations. Certifications include HUBZone, NMSDC MBE, Gateway Checker, and EPCIS 1.2 GS1 compliance, supporting preferential access to 50+ government contracts.
Revenue is generated through quote-based, per-transaction product sales with Net-30 invoice terms for qualified accounts and credit-card processing (1.5% Visa/Mastercard, 3.5% AmEx). Distribution is delivered through personal account managers, an e-commerce portal, and EDI connectivity. The leadership team comprises President Joel Gomez, Strategic Procurement Specialist Sean Shaffer, and Sales Manager Max Lagin; the company operates with 11-50 employees and is founder/management-owned with no disclosed institutional investors.
TCC firmographics
Firmographics- Name
- TCC
- Legal name
- The Compounding Center
- Website
- https://tccpharma.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TCC Pharma is a privately-held, Phoenix-based secondary pharmaceutical and medical-supply distributor serving 500-3,500 healthcare facilities across 45 states with hard-to-find, backordered, and allocated medications under DSCSA-compliant EPCIS 1.2 GS1 standards.
- Ownership category
- akta.pro rank
TCC industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Direct-to-Provider / Clinic Buy-and-Bill Distributors (HLAIAJAM), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Veterinary Vaccine & Biologics Distributors (HLAMAIAC)
Keywords
Where TCC is headquartered
LocationHeadquarters
- HQ city
- Phoenix
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
TCC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Pharmaceutical Distribution: TCC Pharma distributes pharmaceuticals (brand-name and generic) and medical supplies to healthcare facilities. They source hard-to-find, backordered, and allocated products from verified manufacturers and authorized distributors. Revenue is generated through product sales at competitive rates with transparent quoting.
- Medical Supply Distribution: Distribution of medical and surgical supplies including IV fluids, injectables, syringes, wound care, PPE, diagnostics, and facility supplies. Revenue generated through per-transaction product pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pricing for all products |
| Other | Multi-year contract | Net-30 invoice terms for qualified facilities |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
TCC product offering
Product offeringCore offering
TCC Pharma is a licensed wholesale distributor that sources and supplies brand-name and generic pharmaceuticals (including specialty, veterinary-labeled, vaccines/biologics, antibiotics, antifungals, and antivirals), along with medical and surgical supplies such as IV fluids, injectables, syringes, wound care, PPE, diagnostics, and facility supplies. The company specializes as a secondary distributor for hard-to-find, backordered, and allocated products not readily available through primary distributors. It does not supply controlled substances or compounded medications, and serves hospitals, IDNs, ASCs, veterinary hospitals, research organizations, and federal/state healthcare agencies licensed across 45 U.S. states.
Product overview
TCC Pharma operates as a secondary pharmaceutical and medical supply distributor offering a unified distribution platform focused on sourcing hard-to-find products, backorders, and allocated medications. Their core offering combines pharmaceutical distribution (access to 100,000+ NDCs covering brand-name and generic medications, injectables, IV solutions, and specialty drugs) with medical and surgical supplies distribution (wound care, surgical instruments, PPE, diagnostics, IV supplies, and facility supplies). The platform is complemented by EDI EPCIS data exchange services for DSCSA compliance, a customer portal for account management, custom quote request capabilities for sourcing products not listed, and drug shortage resources with early alert subscriptions. TCC does not supply controlled substances or compounded medications. The company is licensed in 45 states and serves hospitals, IDNs, ASCs, specialty practices, research organizations, veterinary facilities, and government agencies.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Sourcing and wholesale distribution of brand-name and generic pharmaceuticals to licensed healthcare facilities across 45 U.S. states. Covers specialty and high-cost medications, veterinary-labeled pharmaceuticals, vaccines and biologics, antibiotics, antifungals, and antivirals. Excludes controlled substances and compounded medications. Specializes in hard-to-find, backordered, and allocated products that primary distributors cannot supply.
- Medical & Surgical Supplies Distribution Wholesale distribution of medical and surgical supplies to healthcare facilities, including wound care, surgical instruments, PPE, diagnostics, IV fluids and supplies, injectables and syringes, laboratory and diagnostic products, nutrition and infusion products, emergency and critical care supplies, and facility supplies. Supports the same secondary-sourcing, hard-to-find model as pharmaceutical distribution.
- EDI / EPCIS Compliance Data Exchange Secure Electronic Data Interchange (EDI) connectivity for order, shipment, and DSCSA compliance-related data exchange with trading partners. Through the Gateway Checker partnership, TCC facilitates serialized transaction data exchange via AS2 and SFTP using EPCIS 1.2 GS1 standards, and maintains compliance records for a minimum of six years. Supports serialization interoperability with downstream trading partners.
Quantifiable outcome
- Trusted by 500+ healthcare facilities across the nation
- +3 more outcomes
Companies that use TCC
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
TCC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration11 records
Feature3 records
TCC partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Gateway CheckercoreGateway Checker is TCC Pharma's technology partner facilitating seamless EPCIS data sharing via secure AS2 and SFTP connections. This partnership enables TCC to maintain DSCSA compliance and provide interoperable serialized transaction data to trading partners.
- Urgent Surgery SolutionscoreSister company of TCC Pharma operating under common ownership/licensing. Both companies share pharmaceutical wholesale licenses in 45 states and collaborate on serving healthcare facility customers with pharmaceuticals and medical supplies.
- GS1 UScoreGS1 US provides Global Location Numbers (GLN) and standards for EPCIS data exchange. TCC Pharma utilizes GS1 standards for serialized transaction data as required by DSCSA, and refers customers needing GLN numbers to GS1 US store.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
TCC competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Cardinal Health is a top-three U.S. pharmaceutical distributor serving hospitals, IDNs, ASCs, and government customers. Comparable in customer base and product breadth to TCC, but operates at vastly larger scale as a primary wholesaler; TCC names it implicitly in the same competitive set.
- Owens & Minor: Owens & Minor is a major U.S. distributor of medical and surgical supplies, including wound care, PPE, and IV products. Comparable to TCC's medical/surgical supply distribution business serving hospitals and ASCs.
- McKesson Medical-Surgical: McKesson Medical-Surgical distributes medical-surgical supplies, equipment, and pharmaceuticals to physician offices, ASCs, and non-acute care facilities. Comparable to TCC's medical/surgical supplies distribution business serving ASCs and clinics.
- Henry Schein: Henry Schein distributes medical, dental, and veterinary supplies and pharmaceuticals to office-based practitioners, including veterinary practices. Comparable to TCC's ASC, clinic, and veterinary distribution lines serving similar non-acute care customer segments.
- McKesson: McKesson is the largest U.S. pharmaceutical wholesaler and a key EDI trading partner of TCC's. Comparable because both distribute pharmaceuticals and medical supplies to hospitals and health systems, though McKesson is a full-line primary distributor serving national accounts while TCC occupies the secondary/backorder niche.
- Cencora (formerly AmerisourceBergen): Cencora is the third Big Three U.S. pharmaceutical distributor with deep specialty and biologics distribution capabilities. Comparable as a broad incumbent in pharmaceutical wholesaling serving similar healthcare provider customers as TCC.
Direct peers
- Anda Inc. (Teva): Anda is the U.S. distribution arm of Teva, distributing generic and specialty pharmaceuticals to pharmacies, hospitals, and alternate-care sites. Comparable as a specialty/generic distributor with hospital and alternate-care reach overlapping TCC's customer base.
- Morris & Dickson: Morris & Dickson is a U.S. secondary pharmaceutical wholesaler that specializes in hard-to-find, backordered, and short-supply drugs to hospitals, health systems, and government facilities. The closest direct competitor to TCC in the secondary-distribution niche.
- Smith Drug Company: Smith Drug Company is a regional pharmaceutical wholesaler distributing brand, generic, and specialty products to independent and regional chain pharmacies. Comparable to TCC as a mid-tier distributor with secondary-sourcing capability serving community and institutional customers.
- H.D. Smith: H.D. Smith is a large U.S. pharmaceutical wholesaler serving retail, hospital, and institutional customers with broad generic, brand, and specialty offerings. Comparable mid-sized competitor in the multi-channel pharmaceutical distribution space TCC occupies.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
TCC social profiles
Digital presenceTCC compliance and trust
Trust signalCompliance5 records
TCC financial estimates
Financial estimateRevenue estimate
Valuation estimate
TCC leadership team
Management profileNumber of profiles
Profiles3 records
TCC subsidiaries and ownership
Company hierarchySubsidiaries1 record
TCC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TCC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TCC
What does TCC do?
TCC Pharma is a licensed wholesale distributor that sources and supplies brand-name and generic pharmaceuticals (including specialty, veterinary-labeled, vaccines/biologics, antibiotics, antifungals, and antivirals), along with medical and surgical supplies such as IV fluids, injectables, syringes, wound care, PPE, diagnostics, and facility supplies. The company specializes as a secondary distributor for hard-to-find, backordered, and allocated products not readily available through primary distributors. It does not supply controlled substances or compounded medications, and serves hospitals, IDNs, ASCs, veterinary hospitals, research organizations, and federal/state healthcare agencies licensed across 45 U.S. states.
Is TCC a public or private company?
TCC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was TCC founded?
TCC was founded in 2001. It employs 11 to 50 people.
Where is TCC based?
TCC is headquartered in Phoenix, United States, in the North America region.
How does TCC make money?
Two revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are medical Supply Distribution.
Who are TCC's main competitors?
Broad incumbents on record are Cardinal Health, Owens & Minor, McKesson Medical-Surgical, Henry Schein, McKesson and Cencora (formerly AmerisourceBergen). Direct peers are Anda Inc. (Teva), Morris & Dickson, Smith Drug Company and H.D. Smith.
Does TCC have an API?
No public API is recorded for TCC.
What industry is TCC in?
TCC's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.